anti-CDKN2D antibody product blog
Tags: Antibody; Monoclonal Antibody; p19INK4d; anti-CDKN2D antibody; CDKN2D;
The CDKN2D cdkn2d (Catalog #MBS604036) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The p19INK4d (cdk4, cdk6 Inhibitor, Mitotic Inhibitor/Suppressor Protein, Cyclin-dependent Kinase Inhibitor) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s p19INK4d can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC).Suitable for use in Immunohistochemistry, Immunoprecipitation and Western Blot.
Dilution: Immunohistochemistry: Frozen sections. Researchers should empirically determine the suitability of the CDKN2D cdkn2d for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The CDKN2D cdkn2d product has the following accession number(s) (GI #1101911) (Uniprot Accession #P55273). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Human p19ink4d is a 19kD tumor suppressor protein which is a specific inhibitor of cdk4/cdk6, periodically expressed during the cell cycle. Maximum induction of p19ink4d occurs as cells enter S phase.
Immunogen: Full length recombinant p19-His tagged. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CDKN2D are readily searchable from our website. Different antibodies against the same target such as CDKN2D may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Carcinoma, Endocrine Gland Neoplasms, Gonadal Disorders, Leukemia, Leukemia, Myeloid, Lymphoma, Neoplasms, Nervous System Diseases, Ovarian Neoplasms, Urogenital Neoplasms are some of the diseases may be linked to p19INK4d (cdk4, cdk6 Inhibitor, Mitotic Inhibitor/Suppressor Protein, Cyclin-dependent Kinase Inhibitor). Blood, Bone, Brain, Embryonic Tissue, Eye, Liver, Lung, Lymph Node, Prostate, Testis tissues are correlated with this protein. The following patways have been known to be associated with this gene. CDKN2D also interacts with the following gene(s): CDK4, CDK6.